title: [Stereotactic body radiation therapy and oligometastases].
abstract: In stage IV cancers, locoregional management of primitive tumours as surgery and/or radiotherapy improved both progression-free survival and overall survival. Among metastatic cancer patients, some of them are considered as oligometastatic stage as they present few metastatic sites associated with low tumor aggressiveness. For those patients, metastatic local control, and therefore prolonged time to progression should be reached through local treatments as surgery and/or radiofrequency ablation and/or stereotactic radiotherapy. Here we propose a review of oligometastatic stage and results from extracranial stereotactic radiotherapy in terms of efficacy and tolerance.
authors.affiliation: Service de radiothérapie, institut régional du cancer de Montpellier, 208, rue des Apothicaires, parc euromédecine, 34298 Montpellier cedex 05, France; Inserm U896, 208, rue des Apothicaires, parc euromédecine, 34298 Montpellier cedex 05, France; U896, université Montpellier 1, 208, rue des Apothicaires, parc euromédecine, 34298 Montpellier cedex 05, France. Electronic address: Celine.Bourgier@icm.unicancer.fr.
authors.forename: C
authors.initials: C
authors.lastname: Bourgier
authors.affiliation: Service de radiothérapie, institut régional du cancer de Montpellier, 208, rue des Apothicaires, parc euromédecine, 34298 Montpellier cedex 05, France; Inserm U896, 208, rue des Apothicaires, parc euromédecine, 34298 Montpellier cedex 05, France; U896, université Montpellier 1, 208, rue des Apothicaires, parc euromédecine, 34298 Montpellier cedex 05, France.
authors.forename: D
authors.initials: D
authors.lastname: Azria
authors.affiliation: Service de radiothérapie, institut régional du cancer de Montpellier, 208, rue des Apothicaires, parc euromédecine, 34298 Montpellier cedex 05, France.
authors.forename: P
authors.initials: P
authors.lastname: Fenoglietto
authors.affiliation: Service de radiothérapie, institut régional du cancer de Montpellier, 208, rue des Apothicaires, parc euromédecine, 34298 Montpellier cedex 05, France; Inserm U896, 208, rue des Apothicaires, parc euromédecine, 34298 Montpellier cedex 05, France.
authors.forename: O
authors.initials: O
authors.lastname: Riou
authors.affiliation: Institut de cancérologie de l'ouest René-Gauducheau, boulevard Jacques-Monod, 44805 Saint-Herblain, France; Inserm UMR, centre de recherche en cancérologie Nantes-Angers, 44007 Nantes cedex 1, France.
authors.forename: M-Y
authors.initials: MY
authors.lastname: Almaghrabi
authors.affiliation: Institut de cancérologie de l'ouest René-Gauducheau, boulevard Jacques-Monod, 44805 Saint-Herblain, France; Inserm UMR, centre de recherche en cancérologie Nantes-Angers, 44007 Nantes cedex 1, France.
authors.forename: S
authors.initials: S
authors.lastname: Supiot
authors.affiliation: Département de radiothérapie-oncologie, centre hospitalier Lyon Sud, 165, chemin du Grand-Revoyet, 69310 Pierre-Bénite, Lyon, France.
authors.forename: F
authors.initials: F
authors.lastname: Mornex
authors.affiliation: Service d'oncologie-radiothérapie, hôpital européen Georges-Pompidou, 20, rue Leblance, 75015 Paris, France; Université Paris Descartes, 12, rue de l'École-de-médecine, 75006 Paris, France.
authors.forename: P
authors.initials: P
authors.lastname: Giraud
mesh_terms: D006801:Humans; D009362:Neoplasm Metastasis / Q000628:therapy*; D009369:Neoplasms / Q000473:pathology / Q000601:surgery*; D018579:Patient Selection; D016634:Radiosurgery; D011879:Radiotherapy Dosage
keywords: Extracranial stereotactic irradiation; Oligometastases; Oligométastase; Radiothérapie stéréotaxie extracrânienne